What this means
This trial was planned to check whether BGE-117 is safe and works for anemia in people 65 and older. It was withdrawn, and no results have been posted, so we cannot tell if it helps.
Plain-English summary written by an AI model from the registry listing.
- Status
- Withdrawn
- Who can join
- Ages 65 and over
- Where
- 13 sites
The science
- Registered title
- Study to Evaluate Efficacy and Safety of BGE-117 in the Treatment of Anemia of Aging
- Trial ID
- NCT04815603 ↗
- Phase
- PHASE 2
- Study type
- interventional
- Conditions
- Anemia
- What is tested
- BGE-117, Placebo
- Sponsor
- BioAge Labs, Inc.
- Ages
- 65 Years to no maximum
- Dates
- First posted Mar 25, 2021 · updated May 5, 2022
Registry summary
The primary objectives of this study to evaluate the safety, tolerability and efficacy of BGE-117 in the treatment of anemia of aging in participants ≥ 65 years of age.
Sites (13)
- Paratus Clinical Research - Western Sydney, Blacktown, New South Wales, Australia
- Emeritus Research Sydney, Botany, New South Wales, Australia
- Northern Beaches Clinical Research, Brookvale, New South Wales, Australia
- Vale Medical Practice, Brookvale, New South Wales, Australia
- Paratus Clinical Research Central Coast, Kanwal, New South Wales, Australia
- Browns Plains Family (Sonic/IPN), Browns Plains, Queensland, Australia
- Parkwood Family Practice (Sonic/IPN), Gold Coast, Queensland, Australia
- AusTrials Taringa, Taringa, Queensland, Australia
- AusTrials Wellers Hill, Tarragindi, Queensland, Australia
- PARC Clinical Research, Adelaide, South Australia, Australia
- Casey Superclinic (Sonic/IPN), Berwick, Victoria, Australia
- Emeritus Research - Camberwell, Camberwell, Victoria, Australia
- Camberwell Road Medical Practice (Sonic/IPN), Hawthorn E., Victoria, Australia